CEPH Message Board - Msg: 1527097

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DIVYA DUTTA who wrote (382)	6/4/1997 4:32:00 AM
From: Rocketman	of 998

CYTO is a hot still relatively undiscovered prospect with no current analyst coverage, which should change in weeks. No FDA risk here, the stuff is approved and going to market and the story just keeps getting better. They are still out of favor due to their old Oncoscint product never making its marketing targets, but they shouldn't have that problem with QUAD the new drug and have Prostascint approved too. CYTO's my second biggest position after my 35 bagger INCY (ex-employee with cheap options to start with). It is also the biggest position in the VD Biotech Model: Subject 14492 Do your own DD of course, nothing is a sure bet, but some are a lot surer than others! Check out MATX and CMTR too. They'll be taking off Wed. on good news that is only just the beginning (IMHO of course). Rman

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next